Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice.
Ciccullo A, Baldin G, Borghi V, Oreni L, Lagi F, Fusco P, Giacomelli A, Torti C, Sterrantino G, Mussini C, Antinori S, Di Giambenedetto S. Ciccullo A, et al. Among authors: antinori s. Int J Antimicrob Agents. 2024 Jan;63(1):107040. doi: 10.1016/j.ijantimicag.2023.107040. Epub 2023 Nov 20. Int J Antimicrob Agents. 2024. PMID: 37981074
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy.
Rizzo A, Pozza G, Salari F, Giacomelli A, Mileto D, Cossu MV, Mancon A, Gagliardi G, Micol B, Micheli V, Capetti A, Antinori S, Gismondo MR, Olivieri P, Lombardi A. Rizzo A, et al. Among authors: antinori s. J Med Virol. 2023 Jan;95(1):e28328. doi: 10.1002/jmv.28328. Epub 2022 Nov 28. J Med Virol. 2023. PMID: 36415133
Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital.
Giacomelli A, Ridolfo AL, Oreni L, Rizzardini G, Antinori S; COVID-Sacco Study group. Giacomelli A, et al. Among authors: antinori s. Eur J Intern Med. 2023 Mar;109:120-122. doi: 10.1016/j.ejim.2022.12.001. Epub 2022 Dec 5. Eur J Intern Med. 2023. PMID: 36481096 Free PMC article. No abstract available.
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
D'arminio Monforte A, Tavelli A, Sala M, Mondi A, Rusconi S, Antinori S, Puoti M, Celesia BM, Taramasso L, Saracino A, Antinori A, Cozzi-Lepri A; ICONA Foundation Study Group. D'arminio Monforte A, et al. Among authors: antinori a, antinori s. J Antimicrob Chemother. 2023 Apr 3;78(4):933-945. doi: 10.1093/jac/dkad026. J Antimicrob Chemother. 2023. PMID: 36775983
Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination.
Pezzati L, Milazzo L, Carrozzo G, Kullmann C, Oreni L, Beltrami M, Caronni S, Lai A, Caberlotto L, Ottomano C, Antinori S, Ridolfo AL. Pezzati L, et al. Among authors: antinori s. J Infect Chemother. 2023 Jun;29(6):624-627. doi: 10.1016/j.jiac.2023.03.002. Epub 2023 Mar 11. J Infect Chemother. 2023. PMID: 36914095 Free PMC article.
378 results